Sign inJoin waitlistJoin the waitlist

RG

Richard Gaynor

Hematology & Oncology

Credentials: ·

Research

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Cell · 2020 · 612 citations
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
Cancer Cell · 2022 · 199 citations
Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation
Molecular Cell · 2005 · Last of 5 authors · 173 citations

UV
Udit Verma
10 papers · 10 as a resident
CB
Carlos Becerra
2 papers
EF
Eugene Frenkel
2 papers
MA
Mark Awad
2 papers
Patrick Ott
2 papers
Ramaswamy Govindan
2 papers
Siwen Hu-Lieskovan
2 papers · 2 as a fellow
AA
Amy Abernethy
1 paper
Andrea Richardson
1 paper
Aung Naing
1 paper
Bartosz Chmielowski
1 paper
BO
Bert O'Malley
1 paper